Marissa Ostroff

Marissa Ostroff serves as Clinical Associate Professor of Ambulatory Care in the Department of Pharmacy Practice at Western New England University College of Pharmacy. Her clinical expertise focuses on chronic disease management, renal pharmacotherapy, and optimizing medication transitions for geriatric and long-term care populations.

Educational background includes:

• Doctor of Pharmacy, Massachusetts College of Pharmacy and Health Sciences
• PGY-1 Pharmacy Practice Residency, VA Connecticut Healthcare System
• PGY-2 Geriatrics Residency, Durham VA Medical Center
• Teaching and Learning Certification, University of Connecticut School of Pharmacy
• Faculty Development Course in Clinical Teaching, Stanford

Her research centers on geriatric pharmacotherapy and chronic kidney disease management, addressing critical gaps in transitions of care and long-term medication safety. Current projects emphasize evidence-based guideline implementation for respiratory conditions and cannabinoid therapeutics, with strong clinical applications in ambulatory settings.

Recent publications reveal consistent focus on clinical guideline translation (GINA asthma, GOLD COPD), emerging cannabinoid applications, and specialized drug interaction profiles. This body of work demonstrates expertise in bridging pharmacotherapy research with practical educational frameworks for complex patient populations.

Professional recognition includes:

• Board Certified Pharmacotherapy Specialist (2013)

Dr. Ostroff actively mentors through course instruction including PHAR710 IPC GI Module, PHAR752 Geriatrics Elective, and renal/special populations courses. Her precepting experience spans Campbell University and UNC Eshelman School of Pharmacy students during residency training, with ongoing curriculum development in geriatric and renal pharmacotherapy.

Her clinical work operates within integrated ambulatory care teams at VA medical centers, focusing on interdisciplinary collaboration for complex chronic disease management in geriatric and renal patient populations.